Cannabis During Pregnancy May Delay a Critical Switch in How Baby Brains Wire Themselves

Narrative review synthesizing evidence on the effects of exogenous cannabinoids on the endocannabinoid and GABAergic systems during neurodevelopment. Focuses on the developmental GABA excitatory-to-inhibitory switch and the consequences of its disruption.

The delayed GABA switch mechanism could explain a wide range of neurodevelopmental effects attributed to prenatal cannabis exposure. Rather than cannabis simply being 'toxic' to the developing brain, it may be disrupting the precise timing of a normal developmental process—which is potentially even more consequential because it affects the foundation on which all subsequent brain development is built.

This provides a unifying mechanism for the diverse neurodevelopmental effects catalogued in RTHC-00209 (prenatal cannabis review) and RTHC-00216 (reproductive effects review). RTHC-00191's finding that timing of prenatal THC exposure matters for amygdala development may be related to the GABA switch timeline in specific brain regions. RTHC-00210's discovery that CB1 activation reduces GABA in the adult prefrontal cortex shows the endocannabinoid-GABA interaction persists throughout life—but during development, disrupting it is particularly consequential.

Much of the GABA switch evidence comes from animal models and in vitro studies. The exact timing and mechanism of the GABA transition vary across brain regions and species. Whether THC exposure at typical human doses is sufficient to delay the switch is uncertain. The review doesn't quantify how much delay in the GABA switch is clinically meaningful. Narrative review format is subject to selection bias.